Thyroid-associated ophthalmopathy: cu-rrent concepts regarding etiopathogenesis and management

Min Chen,Xiang-Tian Zhou,Wen Sheng,Jia Qu

DOI: https://doi.org/10.3969/j.issn.1672-5123.2006.04.042

IF: 1.645

2006-01-01

International Journal of Ophthalmology

Abstract:Thyroid-associated Ophthalmopathy (TAO) is the most frequent autoimmune disease in the orbit disease, which is always related to thyroid disease. Some TAO patients will recover without any treatments. Although characteristic changes in retrobulbar tissues are detectable on orbital imaging in almost all patients with TAO, clinically apparent ophthalmopathy occurs in 30%-50% of patients, with severe and potentially sight-threatening forms affecting 3%-5% of patients. The precise immunopathogenesis remains an enigma. Several clinical studies have provided a more rational basis for treatment of this distressing disease, according to the severity and activity of the eye disease. In recent years Cytokines (TNF et al) have been suggested to play a pivotal role in the pathogenesis of TAO as mediators of autoimmune inflammation, at the heart of orbital susceptibility to Graves' disease appears to be the peculiar phenotype of orbital fibroblasts. With the development of research with regard to immunology, pathology and molecular biology, we will know more about the pathogenesis for the TAO disease, which will also promote to create the new effective drugs and find more reasonable treatment plan.